MA43352B1 - Protéine sans phénylalanine pour le traitement de la phénylcétonurie - Google Patents

Protéine sans phénylalanine pour le traitement de la phénylcétonurie

Info

Publication number
MA43352B1
MA43352B1 MA43352A MA43352A MA43352B1 MA 43352 B1 MA43352 B1 MA 43352B1 MA 43352 A MA43352 A MA 43352A MA 43352 A MA43352 A MA 43352A MA 43352 B1 MA43352 B1 MA 43352B1
Authority
MA
Morocco
Prior art keywords
protein
phenylalanine
food
phenylketonuria
treatment
Prior art date
Application number
MA43352A
Other languages
English (en)
Other versions
MA43352A (fr
Inventor
Bernhard Hoffmann
Yvonne Mücke
Stefan Rasche
Natalia Jablonka
Stefan Schillberg
Original Assignee
Metax Inst Fuer Diaetetik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metax Inst Fuer Diaetetik Gmbh filed Critical Metax Inst Fuer Diaetetik Gmbh
Publication of MA43352A publication Critical patent/MA43352A/fr
Publication of MA43352B1 publication Critical patent/MA43352B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

La présente invention concerne une protéine alimentaire recombinante exempte de phénylalanine et une protéine alimentaire à haute valeur biologique. L'invention concerne en outre un vecteur codant ladite protéine alimentaire, des microorganismes exprimant ladite protéine, un procédé de production de ladite protéine et une composition diététique comprenant ladite protéine destinée à être utilisée comme médicament et / ou aliment à des fins médicales spéciales. Chez les patients présentant des accumulations de phénylalanine dans le corps.
MA43352A 2016-09-01 2016-09-01 Protéine sans phénylalanine pour le traitement de la phénylcétonurie MA43352B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16186895.5A EP3290436B1 (fr) 2016-09-01 2016-09-01 Protéine sans phénylalanine pour le traitement de la phénylcétonurie

Publications (2)

Publication Number Publication Date
MA43352A MA43352A (fr) 2018-03-07
MA43352B1 true MA43352B1 (fr) 2019-08-30

Family

ID=56883591

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43352A MA43352B1 (fr) 2016-09-01 2016-09-01 Protéine sans phénylalanine pour le traitement de la phénylcétonurie

Country Status (27)

Country Link
US (1) US10640538B2 (fr)
EP (1) EP3290436B1 (fr)
JP (1) JP6954676B2 (fr)
CN (1) CN109661401B (fr)
AU (1) AU2017317652B2 (fr)
BR (1) BR112019004270A2 (fr)
CA (1) CA3033271C (fr)
CY (1) CY1121886T1 (fr)
DK (1) DK3290436T3 (fr)
ES (1) ES2742175T3 (fr)
HR (1) HRP20191406T1 (fr)
HU (1) HUE044665T2 (fr)
IL (1) IL265015B2 (fr)
LT (1) LT3290436T (fr)
MA (1) MA43352B1 (fr)
MD (1) MD3290436T2 (fr)
ME (1) ME03510B (fr)
MX (1) MX2019002422A (fr)
NZ (1) NZ750498A (fr)
PL (1) PL3290436T3 (fr)
PT (1) PT3290436T (fr)
RU (1) RU2764796C2 (fr)
SA (1) SA519401175B1 (fr)
SI (1) SI3290436T1 (fr)
UA (1) UA124630C2 (fr)
WO (1) WO2018041920A1 (fr)
ZA (1) ZA201901505B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113214363B (zh) * 2019-09-27 2022-12-06 湖北康肽药业有限公司 一组特殊膳食蛋白质
CN110747218A (zh) * 2019-09-27 2020-02-04 深圳市诺维健生物技术有限责任公司 一种特殊膳食蛋白质的生产方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126051A (ja) * 1990-09-18 1992-04-27 Snow Brand Milk Prod Co Ltd フェニルケトン尿症患者用栄養調製物
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
GB9314802D0 (en) * 1993-07-16 1993-08-25 Pharmaceutical Proteins Ltd Modified proteins
WO1996017064A1 (fr) 1994-12-02 1996-06-06 Indiana University Foundation Proteines sans phenylalanine
EP1092769B1 (fr) * 1999-10-15 2008-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Des "tags" polypeptidiques pour la détection et la purification de polypeptides
DK1339837T3 (da) * 2000-12-07 2008-06-09 Dsm Ip Assets Bv Prolyl-endoprotease fra Aspergillus Niger
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
EP2142651B1 (fr) 2007-04-27 2013-05-22 Pfenex Inc. Procédé pour rapidement cribler des hôtes microbiens et identifier certaines souches ayant un rendement et/ou une qualité d'expression des protéines hétérologues améliorés
WO2010124180A1 (fr) * 2009-04-23 2010-10-28 Phasebio Pharmaceuticals, Inc. Protéine de fusion de phénylalanine hydroxylase et procédés pour traiter une phénylcétonurie
WO2013133691A1 (fr) * 2012-03-09 2013-09-12 N.V. Nutricia Composition nutritionnelle liquide comprenant des acides aminés libres
US20150126441A1 (en) 2012-03-26 2015-05-07 Pronutria, Inc. Nutritive Fragments and Proteins with Low or No Phenylalanine and Methods
EP2922416A4 (fr) 2012-11-20 2016-07-20 Pronutria Inc Protéines sécrétées modifiées et procédés
ES2896401T3 (es) 2014-09-22 2022-02-24 Tanea Medical Ab Proteínas recombinantes exentas de Phe para su uso en el tratamiento de la fenilcetonuria

Also Published As

Publication number Publication date
LT3290436T (lt) 2019-10-10
AU2017317652B2 (en) 2020-11-19
JP6954676B2 (ja) 2021-10-27
HUE044665T2 (hu) 2019-11-28
RU2764796C2 (ru) 2022-01-21
JP2019533988A (ja) 2019-11-28
BR112019004270A2 (pt) 2019-06-04
MA43352A (fr) 2018-03-07
IL265015A (fr) 2019-04-30
WO2018041920A1 (fr) 2018-03-08
CN109661401A (zh) 2019-04-19
UA124630C2 (uk) 2021-10-20
HRP20191406T1 (hr) 2019-11-15
MD3290436T2 (ro) 2019-10-31
US20190202872A1 (en) 2019-07-04
NZ750498A (en) 2023-01-27
RU2019109142A (ru) 2020-10-01
EP3290436B1 (fr) 2019-06-05
DK3290436T3 (da) 2019-08-19
CA3033271C (fr) 2024-04-02
PT3290436T (pt) 2019-08-30
CA3033271A1 (fr) 2018-03-08
IL265015B2 (en) 2024-08-01
RU2019109142A3 (fr) 2021-01-27
PL3290436T3 (pl) 2020-01-31
SA519401175B1 (ar) 2022-01-08
AU2017317652A1 (en) 2019-02-28
SI3290436T1 (sl) 2019-11-29
EP3290436A1 (fr) 2018-03-07
IL265015B1 (en) 2024-04-01
CN109661401B (zh) 2023-12-19
MX2019002422A (es) 2019-07-04
ZA201901505B (en) 2020-08-26
CY1121886T1 (el) 2020-10-14
ES2742175T3 (es) 2020-02-13
ME03510B (fr) 2020-04-20
US10640538B2 (en) 2020-05-05

Similar Documents

Publication Publication Date Title
MX2019012081A (es) Proteina de fusion del factor de crecimiento 21 de fibroblastos humanos (hfgf21), metodo de preparacion de la misma y su uso.
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
MA35507B1 (fr) Protéines à double fonction pour le traitement de troubles du métabolisme
MY173699A (en) Novel compounds for the treatment of diseases associated with amyloid of amyloid-like proteins
WO2012081982A3 (fr) Composition à base de protéines de lactosérum présentant une astringence réduite
MA41067B1 (fr) Composition comportant de la chitine et des protéines digestibles
TR201908777A2 (tr) Suda Çözünür ve Suda Çözünür Olmayan Özellikte Yüksek Antioksidan Kapasitesine Sahip Propolis Ürünleri ve Üretim Yöntemi
MX2021010264A (es) Formulaciones estables de proteina.
WO2017062468A8 (fr) Agonistes de ppar, composés, compositions pharmaceutiques et méthodes d'utilisation de ceux-ci
EA201791537A1 (ru) Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение
MA43352B1 (fr) Protéine sans phénylalanine pour le traitement de la phénylcétonurie
EA201790223A1 (ru) Водный препарат, содержащий парацетамол и ибупрофен
MA45172B1 (fr) Arn modifié codant pour des polypeptides vegf-a, formulations et utilisations associées
WO2020109620A3 (fr) Souches bactériennes pour utilisations médicales
MA43474B1 (fr) Systèmes de formulation pour glycolipides antimicrobiens
MX2019014697A (es) Proteínas del receptor para productos finales de la glicación avanzada (rage) para el tratamiento de fibrosis y enfermedades mediadas por daño al adn.
MX2022001489A (es) Proceso para la preparacion de una composicion que comprende un polipeptido de proteina d.
Yudiansah Faktor-Faktor yang mempengaruhi Sikap Remaja tentang Perilaku Seks Bebas di SMK Bhakti Kencana Subang Tahun 2020
MA50034B1 (fr) Composition de stimulation ovarienne contrôlée
Sirak et al. Immunohistochemical features of root end granuloma in chronic periodontitis
Mohaghegh et al. Correction to: isolated human and livestock echinococcus granulosus genotypes using real-time PCR of cox1 gene in northeast Iran
Bohonovich et al. Late manifest forms of syphilis in previously treated patients
EP4279080A3 (fr) Traitement et prophylaxie d'une infection k. pneumoniae
JP6333933B1 (ja) 絹糸腺発酵液
WO2021121444A3 (fr) Formulation stable et de haute concentration de l'anticorps nimotuzumab